Escherichia coli Sequence Type 410 Is Causing New International High-Risk Clones

Author:

Roer Louise1,Overballe-Petersen Søren1,Hansen Frank1,Schønning Kristian23ORCID,Wang Mikala4,Røder Bent L.5,Hansen Dennis S.6,Justesen Ulrik S.78,Andersen Leif P.8,Fulgsang-Damgaard David9,Hopkins Katie L.10,Woodford Neil10,Falgenhauer Linda11,Chakraborty Trinad11,Samuelsen Ørjan1213,Sjöström Karin14,Johannesen Thor B.1,Ng Kim1,Nielsen Jens15,Ethelberg Steen15,Stegger Marc1ORCID,Hammerum Anette M.1,Hasman Henrik1

Affiliation:

1. Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark

2. Department of Clinical Microbiology, Hvidovre University Hospital, Hvidovre, Denmark

3. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

4. Department of Clinical Microbiology, Aarhus University Hospital, Aarhus, Denmark

5. Department of Clinical Microbiology, Slagelse Hospital, Slagelse, Denmark

6. Department of Clinical Microbiology, Herlev and Gentofte Hospital, Herlev, Denmark

7. Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark

8. Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark

9. Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark

10. Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, London, United Kingdom

11. Institute of Medical Microbiology, Justus Liebig University Giessen and German Centre for Infection Research (DZIF), Partner Site Giessen-Marburg-Langen, Giessen, Germany

12. Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway

13. Department of Pharmacy, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway

14. Public Health Agency of Sweden, Stockholm, Sweden

15. Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

Abstract

Extraintestinal pathogenic Escherichia coli (ExPEC) is the main cause of urinary tract infections and septicemia. Significant attention has been given to the ExPEC sequence type ST131, which has been categorized as a “high-risk” clone. High-risk clones are globally distributed clones associated with various antimicrobial resistance determinants, ease of transmission, persistence in hosts, and effective transmission between hosts. The high-risk clones have enhanced pathogenicity and cause severe and/or recurrent infections. We show that clones of the E. coli ST410 lineage persist and/or cause recurrent infections in humans, including bloodstream infections. We found evidence of ST410 being a highly resistant globally distributed lineage, capable of patient-to-patient transmission causing hospital outbreaks. Our analysis suggests that the ST410 lineage should be classified with the potential to cause new high-risk clones. Thus, with the clonal expansion over the past decades and increased antimicrobial resistance to last-resort treatment options, ST410 needs to be monitored prospectively.

Publisher

American Society for Microbiology

Subject

Molecular Biology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3